Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families.

Preeclampsia is a common, pregnancy-specific disorder characterized by reduced placental perfusion, endothelial dysfunction, elevated blood pressure, and proteinuria. The pathogenesis of this heterogeneous disorder is incompletely understood, but it has a familial component, which suggests that one or more common alleles may act as susceptibility genes. We hypothesized that, in a founder population, the genetic background of preeclampsia might also show reduced heterogeneity, and we have performed a genomewide scan in 15 multiplex families recruited predominantly in the Kainuu province in central eastern Finland. We found two loci that exceeded the threshold for significant linkage: chromosome 2p25, near marker D2S168 (nonparametric linkage [NPL] score 3.77; P=.000761) at 21.70 cM, and 9p13, near marker D9S169 (NPL score 3.74; P=.000821) at 38.90 cM. In addition, there was a locus showing suggestive linkage at chromosome 4q32 between D4S413 and D4S3046 (NPL score 3.13; P=.003238) at 163.00 cM. In the present study the susceptibility locus on chromosome 2p25 is clearly different (21.70 cM) from the locus at 2p12 found in an Icelandic study (94.05 cM) and the locus at 2q23 (144.7 cM) found in an Australian/New Zealand study. The locus at 9p13 has been shown to be a candidate region for type 2 diabetes in two recently published genomewide scans from Finland and China. The regions on chromosomes 2p25 and 9p13 may harbor susceptibility genes for preeclampsia.

[1]  M. Adams,et al.  Recent Segmental Duplications in the Human Genome , 2002, Science.

[2]  D. Gudbjartsson,et al.  A high-resolution recombination map of the human genome , 2002, Nature Genetics.

[3]  J. Kere,et al.  Healing a natural knockout of epithelial organogenesis. , 2002, Trends in molecular medicine.

[4]  M. McCarthy,et al.  Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. , 2002, American journal of human genetics.

[5]  T. Arinami,et al.  Evidence for an Association of the R485K Polymorphism in the Coagulation Factor V Gene with Severe Preeclampsia from Screening 35 Polymorphisms in 27 Candidate Genes , 2001, Thrombosis and Haemostasis.

[6]  H. Stefánsson,et al.  A genome-wide scan for preeclampsia in the Netherlands , 2001, European Journal of Human Genetics.

[7]  M. Daly,et al.  A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population , 2001, Nature Genetics.

[8]  M. Luo,et al.  A genome-wide search for Type II diabetes susceptibility genes in Chinese Hans , 2001, Diabetologia.

[9]  M. Varner,et al.  Paternal and maternal components of the predisposition to preeclampsia. , 2001, The New England journal of medicine.

[10]  S. Brennecke,et al.  An Australian twin study of the genetic basis of preeclampsia and eclampsia. , 2001, American journal of obstetrics and gynecology.

[11]  Jm Roberts,et al.  Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.

[12]  J. Terwilliger,et al.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. , 2000, American journal of human genetics.

[13]  Kenneth Lange,et al.  Use of population isolates for mapping complex traits , 2000, Nature Reviews Genetics.

[14]  K. Kontula,et al.  677 C→T Polymorphism of the Methylenetetrahydrofolate Reductase Gene and Preeclampsia , 2000, Obstetrics and gynecology.

[15]  F. Pipkin.  What Is the Place of Genetics in the Pathogenesis of Pre-Eclampsia? , 1999 .

[16]  F. Broughton Pipkin.  What Is the Place of Genetics in the Pathogenesis of Pre-Eclampsia? , 1999, Neonatology.

[17]  H. Stefánsson,et al.  A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. , 1999, Human molecular genetics.

[18]  H. Laivuori,et al.  Evidence of a state of increased insulin resistance in preeclampsia. , 1999, Metabolism: clinical and experimental.

[19]  B. Fu,et al.  Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. , 1999, Hypertension.

[20]  A. Macdonald,et al.  Twin mothers, pregnancy hypertension and pre‐eclampsia , 1999, British journal of obstetrics and gynaecology.

[21]  R. Ness,et al.  Methylenetetrahydrofolate Reductase Polymorphism, Folate, and Susceptibility to Preeclampsia , 1999, The Journal of the Society for Gynecologic Investigation: JSGI.

[22]  F. Wright,et al.  Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. T. Lie,et al.  Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.

[24]  J. Connor,et al.  Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. , 1997, American journal of human genetics.

[25]  T. Arinami,et al.  Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. , 1997, Journal of medical genetics.

[26]  S. Brennecke,et al.  A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. , 1997, American journal of human genetics.

[27]  R. Ness,et al.  Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. , 1996, American journal of obstetrics and gynecology.

[28]  R. Arngrímsson,et al.  Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. , 1996, Acta obstetricia et gynecologica Scandinavica.

[29]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[30]  R. Arngrímsson,et al.  Death rates from ischemic heart disease in women with a history of hypertension in pregnancy , 1995 .

[31]  S. Purandare,et al.  Angiotensinogen: a candidate gene involved in preeclampsia? , 1993, Nature Genetics.

[32]  J. Lalouel,et al.  A molecular variant of angiotensinogen associated with preeclampsia , 1993, Nature Genetics.

[33]  C. Hayward,et al.  An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. , 1992, American journal of human genetics.

[34]  R. Arngrímsson,et al.  Genetic and familial predisposition to eclampsia and pre‐eclampsia in a defined population , 1990 .

[35]  T. Musci,et al.  Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.

[36]  D. Cooper,et al.  Genetics of hypertension in pregnancy: possible single gene control of pre‐eclampsia and eclampsia in the descendants of eclamptic women , 1986, British journal of obstetrics and gynaecology.

[37]  P. O'Connell,et al.  Linkage of high-density lipoprotein–cholesterol concentrations to a locus on chromosome 9p in Mexican Americans , 2002, Nature Genetics.

[38]  J. Kere,et al.  Human population genetics: lessons from Finland. , 2001, Annual review of genomics and human genetics.

[39]  T Varilo,et al.  Molecular genetics of the Finnish disease heritage. , 1999, Human molecular genetics.

[40]  S. Brennecke,et al.  Angiotensinogen gene variation in a population case‐control study of preeclampsia/eclampsia in Australians and Chinese , 1997, Electrophoresis.